BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 3859360)

  • 21. Comparison of intermittent or continuous methotrexate plus 6-mercaptopurine in regimens for standard-risk acute lymphoblastic leukemia in childhood (JCCLSG-S811). The Japanese Children's Cancer and Leukemia Study Group.
    Koizumi S; Fujimoto T; Takeda T; Yatabe M; Utsumi J; Mimaya J; Ninomiya T; Yanai M
    Cancer; 1988 Apr; 61(7):1292-300. PubMed ID: 3278798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic results of DCMP therapy (2M-80) in acute non-lymphocytic leukemia--the relationship between the residual leukemic cells and duration of remission].
    Moriyama Y; Urushiyama M; Ohnishi M; Koyama S; Hirosawa H; Hanano M; Fuse I; Takai K; Nagayama R; Fujiwara M; Kishi K; Takahashi M; Koike T; Sakai C; Kashimura M; Miura R; Aoyagi A; Sanada M; Hattori A; Shibata A; Shinada S
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1549-54. PubMed ID: 6892201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial.
    Rees JK; Gray RG; Swirsky D; Hayhoe FG
    Lancet; 1986 Nov; 2(8518):1236-41. PubMed ID: 2878130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia.
    Sackmann Muriel F; Svarch E; Pavlovsky S; Bustelo P; Giuntoli J; Vergara B; Garay G; Eppinger-Helft M; Kvicala R; Dibar E
    Cancer Treat Rep; 1984 Apr; 68(4):581-6. PubMed ID: 6370428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination chemotherapy of adult acute lymphoblastic leukemia with randomized central nervous system prophylaxis.
    Omura GA; Moffitt S; Vogler WR; Salter MM
    Blood; 1980 Feb; 55(2):199-204. PubMed ID: 6928104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A study of intermittent alternating drug program reinduction therapy on the frequency and duration of response in adult acute leukemia.
    McCredie KB; Freireich EJ; Bodey GP; Burgess MA; Whitecar JP; Smith TL
    Med Pediatr Oncol; 1976; 2(3):309-18. PubMed ID: 979915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term Results of the Risk-adapted Treatment for Childhood B-Cell Acute Lymphoblastic Leukemia: Report From the Japan Association of Childhood Leukemia Study ALL-97 Trial.
    Horibe K; Yumura-Yagi K; Kudoh T; Nishimura S; Oda M; Yoshida M; Komada Y; Hara J; Tawa A; Usami I; Tanizawa A; Kato K; Kobayashi R; Matsuo K; Hori H;
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):81-89. PubMed ID: 28169879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of CNS relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study.
    Winick NJ; Smith SD; Shuster J; Lauer S; Wharam MD; Land V; Buchanan G; Rivera G
    J Clin Oncol; 1993 Feb; 11(2):271-8. PubMed ID: 8426204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The efficacy of BFM-90 program in the treatment of acute lymphoblastic leukemia in children in the studies of Polish pediatric leukemia/lymphoma group].
    Chybicka A; Bogusławska-Jaworska J; Gorczyńska E; Juszczak K; Armata J; Balcerska A; Balwierz W; Bubała H; Filiks-Litwin B; Kołecki P; Kowalczyk J; Lukowska K; Matysiak M; Rokicka-Milewska R; Rola-Kurc E; Stencel D; Sońta-Jakimczyk D; Strojny W; Wachowiak J; Wieczorek M; Wysocki M; Zelenay E
    Wiad Lek; 1998; 51 Suppl 4():25-32. PubMed ID: 10731940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Significance of recurrence in children with acute lymphatic leukemia].
    Behrendt H; van Leeuwen EF; Schuwirth C; Verkes RJ; Hermans J; van der Does-van den Berg A; van Wering ER
    Tijdschr Kindergeneeskd; 1988 Apr; 56(2):67-72. PubMed ID: 3163855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical and occult testicular relapses in children with acute lymphoblastic leukemia. Treated with the D.74 and pethema 7/78 protocols].
    Ortega JJ; Javier G; Torán N
    An Esp Pediatr; 1984 Sep; 21(3):199-214. PubMed ID: 6594962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Consolidating chemotherapy in the treatment program of acute lymphoblastic leukemia in children].
    Maiakova SA; Makhonova LA
    Vestn Akad Med Nauk SSSR; 1986; (5):15-7. PubMed ID: 3487897
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of adult lymphoblastic leukaemia using cyclical chemotherapy with three combinations of four drugs (COAP, POMP, TRAP schedule).
    Proctor SJ; Finney R; Walker W; Thompson RB
    Postgrad Med J; 1981 Jan; 57(663):19-22. PubMed ID: 6944694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment and prognosis after late relapse in childhood acute lymphoblastic leukemia].
    Ikuta K; Fujioka K; Takahashi H; Sumita H; Sekiguchi H; Hanzawa N; Kai S; Kajigaya Y; Funabiki T; Okuyama T
    Rinsho Ketsueki; 1993 Jun; 34(6):712-7. PubMed ID: 8366572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term relapse-free survival in adult acute lymphoblastic leukemia.
    Gingrich RD; Burns CP; Armitage JO; Aunan SB; Edwards RW; Dick FR; Maguire LC; Leimert JT
    Cancer Treat Rep; 1985 Feb; 69(2):153-60. PubMed ID: 3855697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
    Millot F; Suciu S; Philippe N; Benoit Y; Mazingue F; Uyttebroeck A; Lutz P; Mechinaud F; Robert A; Boutard P; Marguerite G; Ferster A; Plouvier E; Rialland X; Behard C; Plantaz D; Dresse MF; Philippet P; Norton L; Thyss A; Dastugue N; Waterkeyn C; Vilmer E; Otten J;
    J Clin Oncol; 2001 Apr; 19(7):1935-42. PubMed ID: 11283125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central nervous system morbidity following an initial isolated central nervous system relapse and its subsequent therapy in childhood acute lymphoblastic leukemia.
    Ochs JJ; Rivera G; Aur RJ; Hustu HO; Berg R; Simone JV
    J Clin Oncol; 1985 May; 3(5):622-6. PubMed ID: 3858436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.
    Tallman MS; Appelbaum FR; Amos D; Goldberg RS; Livingston RB; Mortimer J; Weiden PL; Thomas ED
    J Clin Oncol; 1987 Jun; 5(6):918-26. PubMed ID: 3585446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of recurrence of acute myeloid leukemia in childhood. A retrospective analysis of recurrence in the AML-BFM-83 study].
    Stahnke K; Ritter J; Schellong G; Beck JD; Kabisch H; Lampert F; Creutzig U
    Klin Padiatr; 1992; 204(4):253-7. PubMed ID: 1518261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential high-dose cytosine arabinoside and L-asparaginase in childhood leukemia in relapse.
    Ettinger LJ; Biener R; Finklestein JZ; Kamalakar P; Jones GR; Avramis VI; Holcenberg JS
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):155-9. PubMed ID: 3859930
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.